PolyPid
PYPD
9 hedge funds and large institutions have $5.18M invested in PolyPid in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
13% more funds holding
Funds holding: 8 → 9 (+1)
2.22% more ownership
Funds ownership: 22.92% → 25.15% (+2.2%)
1% more capital invested
Capital invested by funds: $5.13M → $5.18M (+$50K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$465K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.7K |
| 3 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
+$4.47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$2.68K |
PYPD Hedge Fund Activity: Q2 2024 in Review
9 of the 6,927 institutional investors tracked by Wall St. Rank reported a position in PolyPid (PYPD) for Q2 2024, worth a combined $5.18M — up 0.97% from $5.13M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PYPD positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 1 trimmed.
The largest buyer was ADAR1 Capital Management, opening a new position worth an estimated $465K. The largest seller was DAFNA Capital Management, cutting an estimated $2.68K.
- 9 institutional investors held PolyPid (PYPD) as of Q2 2024, up from 8 in Q1 2024.
- Funds reported $5.18M of PolyPid stock for Q2 2024, up 0.97% quarter-over-quarter.
- 1 fund opened new PolyPid positions in Q2 2024 and 0 closed out, a net change of +1 holder.
- The largest PolyPid buyer in Q2 2024 was ADAR1 Capital Management, an estimated $465K added.
- The largest PolyPid seller in Q2 2024 was DAFNA Capital Management, an estimated $2.68K sold.
Based on aggregated 13F filings for Q2 2024.